What is this study trying to find out about low-grade ovarian or peritoneal tumors?

This study is collecting detailed information about low-grade ovarian and peritoneal tumors to better understand their characteristics, treatments, and outcomes. It aims to create a secure database for future research to help develop improved therapies. The study is sponsored by M.D. Anderson Cancer Center and involves reviewing patient medical records and tissue samples.

Who may be eligible for this low-grade ovarian or peritoneal tumor clinical trial?

Women diagnosed with low-grade ovarian or peritoneal tumors who may have experienced disease progression to a higher-grade carcinoma could be eligible. Key tumor types include low malignant potential ovarian tumors, low-grade serous carcinoma, and psammocarcinoma. Please review eligibility criteria for more details.

Is there any cost to participate in this low-grade ovarian or peritoneal tumor clinical trial?

Study-related care, including data collection and medical record review, is provided at no cost. Personal travel expenses to study sites may vary and are not guaranteed to be covered. Participants can expect their involvement to primarily involve record access and optional tissue sample collection.

Actively Recruiting

FEMALE

ID00488878

Data Collection Study for Women With Low Grade Ovarian and Peritoneal Tumors

Led by M.D. Anderson Cancer Center · Updated on 2026-08-10

2000

Participants Needed

Research Sites

52 weeks

Total Duration

AI-Summary

What this Trial Is About

Researchers are collecting information from female patients with low-grade ovarian and peritoneal tumors to build a detailed database. This project includes both past and current patient data to better understand these tumor types and support future research for improved treatments. The study is observational and involves around 1600 patients, focusing on disease characteristics, treatments, and outcomes. The study gathers data by reviewing patients medical records retrospectively and prospectively. Additionally, residual tumor tissue samples may be collected and stored to establish a tumor bank for future research. This secure database will integrate clinical and research information to allow in-depth analysis of patient outcomes linked to their characteristics and treatments. Participants contribute by allowing access to their medical records and possibly providing leftover tissue samples. Researchers collect data on disease progression, treatments received, and patient outcomes over up to 28 years. The study aims to maintain a secure archive that supports ongoing and future research, with no active treatment or intervention administered during participation.

CONDITIONS

Brief Title

Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors

Who Can Participate

FEMALE

Eligibility Criteria

You may qualify if you...

Patients whose disease progressed to a higher-grade carcinoma since the time of original diagnosis
Diagnosis includes ovarian tumor of low malignant potential
Diagnosis includes low-grade serous carcinoma of the ovary
Diagnosis includes primary peritoneal tumor of low malignant potential
Diagnosis includes low-grade serous carcinoma of the peritoneum
Diagnosis includes psammocarcinoma